Trial
NCT00006478
Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Nebraska
Collaborators
—
Condition
Lymphoma
Intervention
autologous tumor cell vaccine
Why stopped
Genitope suspend drug development by decision made by the FDA March 6, 2008.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-18